Nanordica Medical is a healthtech brand that specializes in the development of advanced nanoparticle-based antibacterial wound care products. They have invented and patented nanotechnology that provides 8 times better treatment for infected wounds compared to the standard of care. This efficiency has been confirmed by the North Estonia Medical Centre.

Nanordica Medical's nanotechnology can be utilized to manufacture a wide range of antibacterial products, including wound dressings, sprays, creams, catheters, and surface coatings. Their products offer numerous advantages, such as 8 times better treatment of infected wounds, effectiveness against drug-resistant bacteria, faster wound closure, and environmental friendliness. Their first product is the advanced antibacterial wound dressing, which has completed preclinical studies and is currently being tested in a pilot clinical study on patients with diabetic foot ulcers.

This wound dressing is indicated for all types of infected wounds, including diabetic foot ulcers, burns, surgical wounds, and more. Nanordica Medical is committed to commercializing their patented antibacterial nanotechnology, and they are open to collaborations for clinical studies and licensing of their technology. Their team consists of experienced professionals in the field of deep tech, business development, and biotech product management.

Overall, Nanordica Medical is a pioneering brand that is revolutionizing wound care with their innovative nanotechnology-based products